Skip to content

www.clinicaltrialsukraine.com use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time, details of which can be found in our cookie policy. However please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.

News

Pharmbiotest Poland attended BIOEurope 2024 in Stockholm

We were thrilled to take part in BIO-Europe 2024 in Stockholm! This year’s event gathered an impressive network of over 5,000 participants from 60 countries, providing our team with invaluable ...

Pharmbiotest Poland team participated in the Conference ” We! Are Clinical Research”!

We are thrilled to share that the Pharmbiotest Poland team participated in the 4th International Conference " We! Are Clinical Research"! It was an incredible opportunity to engage with leading ...

Pharmbiotest took part in the international congress in Rome

Pharmbiotest representatives took part in the congress of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT 2021) held in Rome at the end of September. IATDMCT is ...

Pharmbiotest visited the international exhibition in Milan

Pharmbiotest representatives had been invited and hence took part in the prestigious international pharmaceutical exhibition CPhI Worldwide 2021 in Milan, Italy The event has been visited by 1,400 companies from ...

PHARMBIOTEST supported drug manufacturers and did not discontinue clinical trials at the peak of the pandemics

Clinical and Diagnostic Center Pharmbiotest managed not to suspend the process of conducting clinical trials regardless the quarantine regime in Ukraine imposed because of corona virus SARS-CoV-2 last year. At ...

PHARMBIOTEST have been participated The 2nd Kiev Clinical Research Forum. Global discussing platform for the clinical research industry

The 2nd Kiev Clinical Research Forum aims to bring together 350 international experts from industry, regulatory agencies, academia and non-profit boards to share views and knowledge on clinical research among ...